Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20064211HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS20064150HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44027967HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44049811HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44035846HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TCGA Plot Options
Drug Information
GeneHTR2C
DrugBank IDDB00193
Drug NameTramadol
Target IDBE0000533
UniProt IDP28335
Regulation Typeantagonist
PubMed IDs15105221; 16679816
CitationsOgata J, Minami K, Uezono Y, Okamoto T, Shiraishi M, Shigematsu A, Ueta Y: The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesth Analg. 2004 May;98(5):1401-6, table of contents.@@Horishita T, Minami K, Uezono Y, Shiraishi M, Ogata J, Okamoto T, Shigematsu A: The tramadol metabolite, O-desmethyl tramadol, inhibits 5-hydroxytryptamine type 2C receptors expressed in Xenopus Oocytes. Pharmacology. 2006;77(2):93-9. Epub 2006 May 5.
GroupsApproved; Investigational
Direct Classification
SMILESCOC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C
PathwaysTramadol Metabolism Pathway; Tramadol Action Action Pathway
PharmGKBPA451735
ChEMBLCHEMBL1237044